We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The device uses a technique called hypofractionation, which has shown effectiveness in treating a variety of malignancies, including prostate, breast and lung cancers. Read More
The breakthrough designation applies to use of the device to treat squamous-cell carcinoma of the skin and oral cavity without curative standard of care. Read More
The company has installed the software in large healthcare systems to manage disease areas, such as inflammatory bowel diseases, epilepsy, rheumatology and ovarian cancer. Read More
Micro C works with the company’s OXOS Platform for image management, telehealth collaboration and delivery of artificial intelligence-based diagnostics. Read More
The test has demonstrated 98 percent sensitivity in identifying positive samples and 100 percent specificity in identifying negative samples. Read More